Sort   by:  
 Page size 
TranscriptomicsRNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM)
Cerebral Malaria (HCM) is a serious neurological complication caused by Plasmodium falciparum infection. Currently the only treatment for HCM is the provision of anti-malarial drugs; however, such treatment by itself often fails to prevent death or development of neurological sequelae. To identify n...
ORGANISM(S): Mus musculus 
2018-07-03 | E-MTAB-6474 | biostudies-arrayexpress
TranscriptomicsArtemisinic Acid Production Stress in Yeast
We have enginereed S. cerevisiae to produce high titers of Artemisinic acid, an anti-malarial drug precursor. Here we compare the gene expression profiles of the producer strain (EPY330) and a strain in which the last enzyme of the pathway (CYP71AV1, AMO) was inactivated by a point mutation (EPY338)...
ORGANISM(S): Saccharomyces cerevisiae 
2008-10-15 | E-GEOD-11620 | biostudies-arrayexpress
UnknownGlobal estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
Not available
S-EPMC7573874 | biostudies-literature
GenomicsRNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM)
RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM)
PRJEB24903 | ENA
UnknownCorrelation between anti-malarial and anti-haemozoin activities of anti-malarial compounds.
Not available
S-EPMC7441662 | biostudies-literature
TranscriptomicsATAC-seq of monocytes from patients before and after anti-malarial treatment
Patients received standardized coartem therapy. Briefly, each pill contains 20 mg of artemether and 120 mg of lumefantrine. The dose and total coarse of tablets is based on the patients body weight. Blood was drawn from patients prior to anti-malarial treatment (day 0) and after treatment (day42 for...
ORGANISM(S): Homo sapiens 
2022-04-24 | E-MTAB-11643 | biostudies-arrayexpress
GenomicsATAC-seq of monocytes from patients before and after anti-malarial treatment
ATAC-seq of monocytes from patients before and after anti-malarial treatment
PRJEB52334 | ENA
MetabolomicsMaHPIC Experiment 04: Metabolomics from Macaca mulatta infected with Plasmodium cynomolgi B strain to produce and integrate clinical, hematological, parasitological, and omics measures of acute primary infection and relapses
Malaria-naive male rhesus macaques (Macaca mulatta), approximately three years of age, were inoculated intravenously with salivary gland sporozoites produced and isolated at the Centers for Disease Control and Prevention from multiple Anopheles species (An. dirus, An. gambiae, a...
2017-12-01 | MTBLS517 | MetaboLights
UnknownThe past, present and future of anti-malarial medicines.
Not available
S-EPMC6431062 | biostudies-literature
MetabolomicsMaHPIC Experiment 23: Metabolomics from Macaca mulatta infected with Plasmodium cynomolgi B strain to produce and integrate clinical, hematological, parasitological, and omics measures of acute primary infection and relapses
MaHPIC Experimental Description: Malaria-naive male rhesus macaques (Macaca mulatta), approximately four years of age, were inoculated intravenously with salivary gland sporozoites produced and isolated at the Centers for Disease Control and Prevention from multiple Anopheles species (An. ...
2017-12-11 | MTBLS542 | MetaboLights
Sort   by:  
 Page size